Even as China and Korea are increasing their share in the $62 billion herbal drugs market worldwide, Indian exporters of ayurvedic drugs are finding it extremely difficult to tap this high-growth segment.
There are a number of big names like Lupin, Cipla, Alkem and J B Chemicals in this area, but exports of herbal or ayurveda medicines from India stand at a tiny $0.25 billion.
Exporters have been strapped by a European Union (EU) stipulation that requires 30 years safe usage data. This effectively prevents the entry of new players from India who also face the possibility of being blacklisted for the presence of heavy metals in their medicines.
Read the remaining story at source: Business Standard
Random Ayurveda News
- Zen Resort Bali Surya Meditation and Ayurveda Retreat: Inner Peace… (0)
Zen Resort Bali Surya Meditation and Ayurveda Retreat: Inner Peace and Divine Healing Power with Swathimaa and Raymond Prohs
Zen Resort situated in a serene and peaceful environment in north Bali, surrounded by rice fields, vineyards and natural f... - International Ayurveda Symposium held in Germany (0)
Dr Mukesh D Jain director of the Ayush Samiti, Bhilai, Chhattisgarh delivered a guest lecture and spoke on Role of Ayurveda in the Management of Neuro-Muscular diseases at 12th International Ayurveda Symposium recently held in Birstein, Germany. The... - Website on Indian Medicines & Govt Schemes launched (0)
A web portal - www.bharathgramarogya.net - was launched by eminent scientist MS Swaminathan and the 95th Indian Science Congress (ISC) general president R Ramamurthi during the sectional activities of Information and Communication Science and Technol... - Nod to B-Pharma courses at Paprola college (6)
Shimila: The Government of India has given its approval to the state government to start B-Pharmacy courses at Rajiv Gandhi Government Ayurvedic College, Paprola, from the coming academic session.
Ayurveda adviser to the Government of India Dr SK ...
